Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype


  • Potential conflicts of interest: Milan J. Sonneveld has received speaker's fees from Roche. Willem P. Brouwer has nothing to disclose. Prof.dr. H.L.A. Janssen received grants from and is a consultant for: Bristol Myers Squibb, Gilead Sciences, Novartis, Roche, and Schering Plough.

No abstract is available for this article.